Industry Advises No FDA Regulation for Some mHealth Devices

Devices & Diagnostics Letter
An industry group is advising the FDA to not regulate certain mobile health (mHealth) products, which can include medical smart phone applications, because their “social benefit” outweighs their inherent low risk.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00